Story perspectives

High-Dose Niacin Shows Promise Against Glioblastoma in Trials

4/1/2026

Summary

Story summary

High-dose vitamin B3 (niacin) may boost immune activity and help control glioblastoma, per early studies from the University of Calgary.
In trials with 24 patients, 82% showed no disease progression after six months with niacin, vs 54% typically.
Niacin restored immune cell function, enhancing the ability to target tumors.
Researchers caution that the small sample size requires larger trials to confirm results and note health risks from high vitamin doses.

1 of 1

Story summary

High-dose vitamin B3 (niacin) may boost immune activity and help control glioblastoma, per early studies from the University of Calgary.
In trials with 24 patients, 82% showed no disease progression after six months with niacin, vs 54% typically.
Niacin restored immune cell function, enhancing the ability to target tumors.
Researchers caution that the small sample size requires larger trials to confirm results and note health risks from high vitamin doses.